BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Hernandez-Alejandro R, Croome KP, Drage M, Sela N, Parfitt J, Chandok N, Marotta P, Dale C, Wall W, Quan D. A comparison of survival and pathologic features of non-alcoholic steatohepatitis and hepatitis C virus patients with hepatocellular carcinoma. World J Gastroenterol 2012; 18(31): 4145-4149 [PMID: 22919246 DOI: 10.3748/wjg.v18.i31.4145]
URL: https://www.wjgnet.com/1007-9327/full/v18/i31/4145.htm
Number Citing Articles
1
Ryan M. Gill, Sanjay Kakar. Nonalcoholic SteatohepatitisSurgical Pathology Clinics 2013; 6(2): 227 doi: 10.1016/j.path.2013.03.002
2
Sara M. Lewin, Neil Mehta, R. Kate Kelley, John P. Roberts, Francis Y. Yao, Danielle Brandman. Liver transplantation recipients with nonalcoholic steatohepatitis have lower risk hepatocellular carcinomaLiver Transplantation 2017; 23(8): 1015 doi: 10.1002/lt.24764
3
Rocío Llorca, Jorge Funuyet, Manuel Romero-Gómez. Cirrhosis is less cirrhosis without virus CAnnals of Hepatology 2013; 12(2): 341 doi: 10.1016/S1665-2681(19)31377-8
4
Hua Qu, Hang Wang, Min Deng, Huili Wei, Huacong Deng, Partha Mukhopadhyay. Associations between Longer Habitual Day Napping and Non-Alcoholic Fatty Liver Disease in an Elderly Chinese PopulationPLoS ONE 2014; 9(8): e105583 doi: 10.1371/journal.pone.0105583
5
Masamichi Hayashi, Suguru Yamada, Hiroshi Tanabe, Hideki Takami, Yoshikuni Inokawa, Fuminori Sonohara, Dai Shimizu, Norifumi Hattori, Mitsuro Kanda, Chie Tanaka, Goro Nakayama, Masahiko Koike, Michitaka Fujiwara, Yasuhiro Kodera. High Serum Uric Acid Levels Could Be a Risk Factor of Hepatocellular Carcinoma RecurrencesNutrition and Cancer 2021; 73(6): 996 doi: 10.1080/01635581.2020.1779758
6
Lorenzo A. Orci, Marco Sanduzzi-Zamparelli, Berta Caballol, Victor Sapena, Nicola Colucci, Ferran Torres, Jordi Bruix, María Reig, Christian Toso. Incidence of Hepatocellular Carcinoma in Patients With Nonalcoholic Fatty Liver Disease: A Systematic Review, Meta-analysis, and Meta-regressionClinical Gastroenterology and Hepatology 2021;  doi: 10.1016/j.cgh.2021.05.002
7
Trevor W Reichman, George Therapondos, Maria-Stella Serrano, John Seal, Rachel Evers-Meltzer, Humberto Bohorquez, Ari Cohen, Ian Carmody, Emily Ahmed, David Bruce, George E Loss. “Weighing the risk”: Obesity and outcomes following liver transplantationWorld Journal of Hepatology 2015; 7(11): 1484-1493 doi: 10.4254/wjh.v7.i11.1484
8
Aleksandra Berkan-Kawińska, Anna Piekarska. Hepatocellular carcinoma in non-alcohol fatty liver disease – changing trends and specific challengesCurrent Medical Research and Opinion 2020; 36(2): 235 doi: 10.1080/03007995.2019.1683817
9
Rohit Kohli, Shikha Sunduram, Marialena Mouzaki, Sabina Ali, Pushpa Sathya, Stephanie Abrams, Stavra A. Xanthakos, Miriam Vos, Jeffrey B. Schwimmer. Pediatric Nonalcoholic Fatty Liver Disease: A Report from the Expert Committee on Nonalcoholic Fatty Liver Disease (ECON)The Journal of Pediatrics 2016; 172: 9 doi: 10.1016/j.jpeds.2015.12.016
10
Jihane N. Benhammou, Elizabeth S. Aby, Gayaneh Shirvanian, Kohlett Manansala, Shehnaz K. Hussain, Myron J. Tong. Improved survival after treatments of patients with nonalcoholic fatty liver disease associated hepatocellular carcinomaScientific Reports 2020; 10(1) doi: 10.1038/s41598-020-66507-7
11
Carrie R Wong, Mindie H Nguyen, Joseph K Lim. Hepatocellular carcinoma in patients with non-alcoholic fatty liver diseaseWorld Journal of Gastroenterology 2016; 22(37): 8294-8303 doi: 10.3748/wjg.v22.i37.8294
12
Beatriz Castelló, Victoria Aguilera, M. Teresa Blázquez, Ángel Rubín, María García, Carmen Vinaixa, Salvador Benlloch, Fernando SanJuan, Eva Montalva, Rafael López, Marina Berenguer. Post-transplantation outcome in non-alcoholic steatohepatitis cirrhosis: Comparison with alcoholic cirrhosisAnnals of Hepatology 2019; 18(6): 855 doi: 10.1016/j.aohep.2019.06.014
13
Jonathan Merola, AnnMarie Liapakis, David C. Mulligan, Peter S. Yoo. Non-alcoholic fatty liver disease following liver transplantation: a clinical reviewClinical Transplantation 2015; 29(9): 728 doi: 10.1111/ctr.12585
14
Srinevas K. Reddy, David A. Geller. Blumgart's Surgery of the Liver, Biliary Tract and Pancreas, 2-Volume Set2017; : 1065 doi: 10.1016/B978-0-323-34062-5.00071-6
15
Jonathan G. Stine, Brian J. Wentworth, Alex Zimmet, Mary E. Rinella, Rohit Loomba, Stephen H. Caldwell, Curtis K. Argo. Systematic review with meta-analysis: risk of hepatocellular carcinoma in non-alcoholic steatohepatitis without cirrhosis compared to other liver diseasesAlimentary Pharmacology & Therapeutics 2018; 48(7): 696 doi: 10.1111/apt.14937
16
Tomomi Kogiso, Katsutoshi Tokushige. The Current View of Nonalcoholic Fatty Liver Disease-Related Hepatocellular CarcinomaCancers 2021; 13(3): 516 doi: 10.3390/cancers13030516
17
Hepatitis C Virus Enhances the Invasiveness of Hepatocellular Carcinoma via EGFR-Mediated Invadopodia Formation and ActivationCells 2019; 8(11): 1395 doi: 10.3390/cells8111395
18
Darren Hiu-Sun Foog, Deborah Kwok, Becky Ching-Yeung Yu, Vincent Wai-Sun Wong. Managing HCC in NAFLDCurrent Hepatology Reports 2017; 16(4): 374 doi: 10.1007/s11901-017-0376-4